Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Not Confirmed
Not Confirmed
26-29 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Industry Trade Show
Not Confirmed
26-29 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

15 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/15/3166960/0/en/Minovia-Therapeutics-Receives-FDA-Orphan-Drug-Designation-for-MNV-201-in-Myelodysplastic-Syndrome.html

18 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/18/3152312/0/en/Minovia-Therapeutics-Receives-FDA-Fast-Track-Designation-for-MNV-201-in-Myelodysplastic-Syndrome.html

27 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/27/3139893/0/en/Minovia-Therapeutics-Announces-350-000-Grant-from-Countdown-for-a-Cure-Foundation-to-Develop-Mitochondria-Blood-Based-Biomarkers.html

24 Jun 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/minovia-brings-back-spac-plans-skate-icy-public-market

03 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/03/3055005/0/en/Minovia-Therapeutics-Announces-FDA-Clearance-of-Second-IND-Application-for-a-Phase-II-Clinical-Trial-of-Lead-Product-MNV-201-in-Pearson-Syndrome.html

26 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/26/2954055/0/en/Minovia-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-a-Phase-Ib-Clinical-Trial-of-MNV-201-in-Low-Risk-Myelodysplastic-Syndrome.html
ABOUT THIS PAGE